Cargando…
Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials
The treatment of chronic lymphocytic leukemia (CLL) currently relies on the use of chemo-immunotherapy, Bruton’s tyrosine kinase inhibitors, or BCL2 inhibitors alone or combined with an anti-CD20 monoclonal antibody. However, the availability of multiple choices for the first-line setting and a lack...
Autores principales: | Rizzuto, Andrea, Pirrera, Angelo, Gigliotta, Emilia, Mancuso, Salvatrice, Vullo, Candida, Camarda, Giulia Maria, Rotolo, Cristina, Roppolo, Arianna, Spoto, Corinne, Gentile, Massimo, Botta, Cirino, Siragusa, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298034/ https://www.ncbi.nlm.nih.gov/pubmed/37373078 http://dx.doi.org/10.3390/ijms24129930 |
Ejemplares similares
-
Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome
por: Plano, Federica, et al.
Publicado: (2023) -
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again
por: Plano, Federica, et al.
Publicado: (2023) -
Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
por: Botta, Cirino, et al.
Publicado: (2022) -
Familial essential thrombocythemia: 6 cases from a mono‐institutional series
por: Accurso, Vincenzo, et al.
Publicado: (2022) -
Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy
por: Mancuso, Salvatrice, et al.
Publicado: (2022)